Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced acute malaria.

A Skoutelis1, A Symeonidis, E Vassalou

  • 1Department of Medicine, Patras University Medical School, Athens.

Scandinavian Journal of Infectious Diseases
|July 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishing nationally representative central line-associated bloodstream infection surveillance data for paediatric patients in Greece.

The Journal of hospital infection·2018
Same author

Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2017
Same author

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes.

Leukemia·2017
Same author

Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.

Blood cells, molecules & diseases·2017
Same author

Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes.

Blood cancer journal·2017
Same author

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome.

Journal of internal medicine·2016

A rare case of Plasmodium malariae malaria reactivated after 45 years of latency in an elderly woman treated with immunosuppressants is presented. This highlights potential long-term risks of latent malaria reactivation.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Tropical Medicine

Background:

  • Plasmodium malariae malaria is typically characterized by quartan fever cycles.
  • Latent malaria infections can persist for decades, particularly in individuals with compromised immune systems.
  • Immunosuppressive therapies are known to increase the risk of opportunistic infections and reactivation of latent pathogens.

Observation:

  • An elderly woman presented with acute Plasmodium malariae infection.
  • The infection reactivated after a remarkable 45-year latency period.
  • The patient had previously been treated with chlorambucil and methylprednisolone, potent immunosuppressive agents.

Findings:

  • This case represents a unique instance of long-term latent Plasmodium malariae reactivation.

Related Experiment Videos

  • The reactivation was triggered by immunosuppressive treatment, suggesting a link between iatrogenic immune suppression and malaria relapse.
  • Only one prior report documented methotrexate-induced acute malaria reactivation in the English literature.
  • Implications:

    • Clinicians should consider the possibility of latent malaria reactivation in patients on long-term immunosuppressive therapy, especially those with a history of malaria exposure.
    • This case underscores the importance of vigilant monitoring for parasitic infections in immunocompromised individuals.
    • Further research is warranted to understand the mechanisms of long-term malaria latency and reactivation, particularly in the context of modern immunosuppressive treatments.